|
|
Office Locations:
|
155 Avenue of the Americas Suite 301
New York, NY 10013
Phone: 646-503-2200
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Oxeon Partners is a healthcare growth services firm with divisions that include Executive Search and direct investments. The firm connects its healthcare company partners with the fundamental drivers of business growth -- great people, great business development partnerships, strategic investments, next generation business ideas and other growth-related services. Oxeon actively looks to invest capital across the healthcare technology and service industries, both within and outside of its executive search portfolio. Oxeon's Venture Studio builds products and companies de novo. The firm's companies are built in joint ventures with leading healthcare companies, in partnerships with leading healthcare entrepreneurs as well as within Oxeon Holdings. Through insights collected from their relationship network and over 20,000 healthcare conversations annually, the team fills unmet marketplace needs with purpose-built products and companies. 11 early-stage investments have gone on to become unicorns.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
